Raphael Rosenhek

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. ncbi Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis
    Jutta Bergler-Klein
    Department of Cardiology and the Ludwig Boltzmann Institute of Cardiovascular Research, University of Vienna, Vienna, Austria
    Circulation 109:2302-8. 2004
  2. ncbi Natural history of very severe aortic stenosis
    Raphael Rosenhek
    Department of Cardiology, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Circulation 121:151-6. 2010
  3. ncbi ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease
    Raphael Rosenhek
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Eur Heart J 33:822-8, 828a, 828b. 2012
  4. ncbi Aortic sclerosis, aortic stenosis and lipid-lowering therapy
    Raphael Rosenhek
    Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Wien, Austria
    Expert Rev Cardiovasc Ther 6:385-90. 2008
  5. ncbi Management of valvular mitral regurgitation: the importance of risk stratification
    Raphael Rosenhek
    Department of Cardiology, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    J Cardiol 56:255-61. 2010
  6. ncbi [Aortic stenosis]
    Raphael Rosenhek
    Division of Cardiology, Department of Medicine II, Medical University of Vienna, 1090 Vienne, Autriche
    Rev Prat 59:178-81. 2009
  7. ncbi Watchful waiting for severe mitral regurgitation
    Raphael Rosenhek
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Semin Thorac Cardiovasc Surg 23:203-8. 2011
  8. ncbi Outcome of watchful waiting in asymptomatic severe mitral regurgitation
    Raphael Rosenhek
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Circulation 113:2238-44. 2006
  9. ncbi Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis
    Raphael Rosenhek
    Department of Cardiology, Vienna General Hospital, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090 Wien, Austria
    Circulation 110:1291-5. 2004
  10. ncbi Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation
    Ursula Klaar
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Eur J Heart Fail 13:163-9. 2011

Detail Information

Publications26

  1. ncbi Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis
    Jutta Bergler-Klein
    Department of Cardiology and the Ludwig Boltzmann Institute of Cardiovascular Research, University of Vienna, Vienna, Austria
    Circulation 109:2302-8. 2004
    ..Thus, neurohormones may gain particular importance for timing of surgery in asymptomatic severe AS...
  2. ncbi Natural history of very severe aortic stenosis
    Raphael Rosenhek
    Department of Cardiology, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Circulation 121:151-6. 2010
    ..We sought to assess the outcome of asymptomatic patients with very severe aortic stenosis...
  3. ncbi ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease
    Raphael Rosenhek
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Eur Heart J 33:822-8, 828a, 828b. 2012
    ..The Working Group on Valvular Heart Disease of the European Society of Cardiology reviewed the performance of currently available scores when applied to VHD, in order to guide clinical practice and future development of new scores...
  4. ncbi Aortic sclerosis, aortic stenosis and lipid-lowering therapy
    Raphael Rosenhek
    Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Wien, Austria
    Expert Rev Cardiovasc Ther 6:385-90. 2008
    ..Lipid-lowering therapy with statins can, therefore, currently only be recommended in this subgroup of patients with AS...
  5. ncbi Management of valvular mitral regurgitation: the importance of risk stratification
    Raphael Rosenhek
    Department of Cardiology, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    J Cardiol 56:255-61. 2010
    ....
  6. ncbi [Aortic stenosis]
    Raphael Rosenhek
    Division of Cardiology, Department of Medicine II, Medical University of Vienna, 1090 Vienne, Autriche
    Rev Prat 59:178-81. 2009
    ..It should be considered that rapid progression from mild or moderate to severe stenosis is common and may be more rapid than previously assumed...
  7. ncbi Watchful waiting for severe mitral regurgitation
    Raphael Rosenhek
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Semin Thorac Cardiovasc Surg 23:203-8. 2011
    ....
  8. ncbi Outcome of watchful waiting in asymptomatic severe mitral regurgitation
    Raphael Rosenhek
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Circulation 113:2238-44. 2006
    ....
  9. ncbi Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis
    Raphael Rosenhek
    Department of Cardiology, Vienna General Hospital, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090 Wien, Austria
    Circulation 110:1291-5. 2004
    ..Although several studies also suggest that statins may reduce the hemodynamic progression of aortic stenosis (AS), no data are available for ACEIs or the combination of both...
  10. ncbi Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation
    Ursula Klaar
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Eur J Heart Fail 13:163-9. 2011
    ..The role of brain-type natriuretic peptide (BNP) in this setting remains controversial. We evaluated the value of serial BNP measurements for early prediction of deterioration in asymptomatic MR...
  11. ncbi Big endothelin-1 is not a predictor in aortic stenosis, but is related to arterial blood pressure
    Jutta Bergler-Klein
    Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Int J Cardiol 113:174-80. 2006
    ..Elevated big endothelin-1 (bigET) is associated with poor prognosis in chronic heart failure, but little is known about its role in severe aortic stenosis...
  12. ncbi Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography
    Raphael Rosenhek
    Department of Cardiology, Vienna General Hospital, University of Vienna, Vienna, Austria
    Eur Heart J 25:199-205. 2004
    ..Significant valve calcification, CAD and rapid progression of aortic jet velocity indicate poor outcome. Patients with these characteristics may require closer follow-up than generally assumed...
  13. ncbi Gender differences in clinical presentation and surgical outcome of aortic stenosis
    Christina Fuchs
    Department of Cardiology, Medical University of Vienna, University Hospital, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Heart 96:539-45. 2010
    ..Little is known about the gender differences of patients undergoing aortic valve replacement (AVR) for isolated severe aortic stenosis...
  14. ncbi Normal values for Doppler echocardiographic assessment of heart valve prostheses
    Raphael Rosenhek
    Department of Cardiology, Vienna General Hospital, University of Vienna, Austria
    J Am Soc Echocardiogr 16:1116-27. 2003
    ..This study provides an updated overview on the available data of normal values to facilitate adequate interpretation of Doppler data...
  15. ncbi Benefit of atrial septal defect closure in adults: impact of age
    Michael Humenberger
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Eur Heart J 32:553-60. 2011
    ..To evaluate the effect of age on the clinical benefit of atrial septal defect (ASD) closure in adults...
  16. ncbi Value and limitations of aortic valve resistance with particular consideration of low flow-low gradient aortic stenosis: an in vitro study
    Julia Mascherbauer
    Department of Bioengineering, Vienna General Hospital, University of Vienna, Vienna, Austria
    Eur Heart J 25:787-93. 2004
    ..However, values between 120 and 180 dyne s cm(-5) are nondiagnostic, requiring repeated AVA calculations after flow normalisation...
  17. ncbi Doppler echocardiographic assessment of valvular regurgitation severity by measurement of the vena contracta: an in vitro validation study
    Julia Mascherbauer
    Department of Cardiology, Vienna General Hospital, University of Vienna, Vienna, Austria
    J Am Soc Echocardiogr 18:999-1006. 2005
    ..Nevertheless, they allow semiquantitative assessment of valvular regurgitation separating severe from nonsevere regurgitation with acceptable accuracy...
  18. ncbi Hand-held miniaturized cardiac ultrasound instruments for rapid and effective bedside diagnosis and patient screening
    Christine Scholten
    Department of Cardiology, University of Vienna, Vienna, Austria
    J Eval Clin Pract 11:67-72. 2005
    ....
  19. ncbi Vascular dysfunction after coarctation repair is related to the age at surgery
    Maria Heger
    Department of Cardiology, Vienna General Hospital University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Int J Cardiol 99:295-9. 2005
    ..Persistent impairment of arterial dilation has been suspected to contribute to abnormal blood pressure regulation. We tested the hypothesis that arterial reactivity is more likely to be impaired in patients corrected at older age...
  20. ncbi Intraoperative transesophageal echocardiography in valve replacement surgery
    Raphael Rosenhek
    Department of Cardiology, Vienna General Hospital, University of Vienna, Wahringer Gurtel 18 20, A 1090 Wien, Austria
    Echocardiography 19:701-7. 2002
    ..Furthermore, a description of the value of IOTEE in newer procedures, such as port access surgery, is presented...
  21. ncbi Long-term results of thoracic endovascular aortic repair in atherosclerotic aneurysms involving the descending aorta
    Martin Czerny
    Department of Cardiovascular Surgery, University Hospital Berne, Berne, Switzerland
    J Thorac Cardiovasc Surg 140:S179-84; discussion S185-S190. 2010
    ..This study evaluated long-term results of thoracic endovascular aortic repair for atherosclerotic aneurysms involving descending aorta...
  22. ncbi Fibrinolytic balance of the arterial wall: pulmonary artery displays increased fibrinolytic potential compared with aorta
    Raphael Rosenhek
    Department of Cardiology, University of Vienna, and the Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria
    Lab Invest 83:871-6. 2003
    ..Pa endothelial cell-conditioned media revealed increased t-PA/PAI-1 antigen ratios. Taken together, our data indicate that the balance between t-PA and PAI-1 is shifted in human main Pa to favor net PA activity...
  23. ncbi Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure
    Daniel Zimpfer
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    J Thorac Cardiovasc Surg 137:963-70. 2009
    ..Direct application of low-energy unfocused shock waves induces angiogenesis in ischemic soft tissue. The potential effects of epicardial shock wave therapy applied in direct contact to ischemic myocardium are uncertain...
  24. ncbi Serum glutathione S-transferase P1 1 in prediction of cardiac function
    Olena Andrukhova
    Center for Anatomy and Cell Biology, Department of Cardiovascular Research, Vienna, Austria
    J Card Fail 18:253-61. 2012
    ..We hypothesized that GSTP1 might be a useful serum marker in the monitoring of HF patients...
  25. ncbi Statins for aortic stenosis
    Raphael Rosenhek
    N Engl J Med 352:2441-3. 2005
  26. ncbi Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
    Alec Vahanian
    Service de cardiologie, , Paris, France
    Eur Heart J 28:230-68. 2007